Table 1 Baseline characteristics, cardiovascular risk factors, prior cardiovascular diseases, revascularisations and medications in the protocol and non-protocol treated groups
Protocol | Non-protocol | p | |
|---|---|---|---|
n = 99 | n = 291 | ||
Mean age, years, mean (SD) | 59.5 (14) | 66.1 (14) | <0.001 |
Age > 75 years, n (%) | 11 (11.1) | 97 (33.3) | <0.001 |
Male sex, n (%) | 74 (74.7) | 198 (68.0) | 0.210 |
Diabetes, n (%) | 13 (13.1) | 64 (22.0) | 0.056 |
Current smoker, n (%) | 50 (50.5) | 95 (32.6) | 0.001 |
Hypertension, n (%) | 49 (49.5) | 158 (54.3) | 0.408 |
Dyslipidaemia, n (%) | 39 (39.4) | 123 (42.3) | 0.616 |
Renal dysfunctiona, n (%) | 3 (3.0) | 11 (3.8) | 0.729 |
Peripheral vascular disease, n (%) | 4 (4.0) | 14 (4.8) | 0.752 |
Previous myocardial infarction, n (%) | 9 (9.1) | 32 (11.0) | 0.593 |
Previous stroke, n (%) | 4 (4.0) | 21 (7.2) | 0.265 |
Previous CABG, n (%) | 1 (1.0) | 15 (5.2) | 0.073 |
Previous PCI, n (%) | 10 (10.1) | 39 (13.4) | 0.392 |
Aspirin, n (%) | 21 (21.2) | 81 (27.8) | 0.195 |
P2Y12-receptor inhibitor, n (%) | 2 (2.0) | 11 (3.8) | 0.399 |
Warfarin, n (%) | 2 (2.0) | 37 (12.7) | 0.002 |